188 related articles for article (PubMed ID: 20452758)
1. Mediators of inflammation in nasal lavage from aspirin intolerant patients after aspirin challenge.
Kupczyk M; Kurmanowska Z; Kupryś-Lipińska I; Bocheńska-Marciniak M; Kuna P
Respir Med; 2010 Oct; 104(10):1404-9. PubMed ID: 20452758
[TBL] [Abstract][Full Text] [Related]
2. Intranasal challenge with aspirin induces cell influx and activation of eosinophils and mast cells in nasal secretions of ASA-sensitive patients.
Kowalski ML; Grzegorczyk J; Wojciechowska B; Poniatowska M
Clin Exp Allergy; 1996 Jul; 26(7):807-14. PubMed ID: 8842555
[TBL] [Abstract][Full Text] [Related]
3. Chemokine CC-ligand 5 production and eosinophil activation into the upper airways of aspirin-sensitive patients.
Fuentes-Beltrán A; Montes-Vizuet R; Valencia-Maqueda E; Negrete-García MC; García-Cruz Mde L; Teran LM
Clin Exp Allergy; 2009 Apr; 39(4):491-9. PubMed ID: 19226274
[TBL] [Abstract][Full Text] [Related]
4. Changes in urinary LTE4 and nasal functions following nasal provocation test with ASA in ASA-tolerant and -intolerant asthmatics.
Micheletto C; Tognella S; Visconti M; Trevisan F; Dal Negro RW
Respir Med; 2006 Dec; 100(12):2144-50. PubMed ID: 16678396
[TBL] [Abstract][Full Text] [Related]
5. Specific immunoglobulin E for staphylococcal enterotoxins in nasal polyps from patients with aspirin-intolerant asthma.
Suh YJ; Yoon SH; Sampson AP; Kim HJ; Kim SH; Nahm DH; Suh CH; Park HS
Clin Exp Allergy; 2004 Aug; 34(8):1270-5. PubMed ID: 15298569
[TBL] [Abstract][Full Text] [Related]
6. Lipoxin A4 generation is decreased in aspirin-sensitive patients in lysine-aspirin nasal challenge in vivo model.
Kupczyk M; Antczak A; Kuprys-Lipinska I; Kuna P
Allergy; 2009 Dec; 64(12):1746-52. PubMed ID: 19385948
[TBL] [Abstract][Full Text] [Related]
7. Challenge of isolated sputum cells supports in vivo origin of intolerance reaction to aspirin/non-steroidal anti-inflammatory drugs in asthma.
Higashi A; Kumlin M; Higashi N; Daham K; Gaber F; Lindeberg A; James A; Skedinger M; Delin I; Gyllfors P; Dahlén SE; Dahlén B
Int Arch Allergy Immunol; 2012; 158(3):299-306. PubMed ID: 22398682
[TBL] [Abstract][Full Text] [Related]
8. Effect of inhalation aspirin challenge on exhaled nitric oxide in patients with aspirin-inducible asthma.
Rolla G; Di Emanuele A; Dutto L; Marsico P; Nebiolo F; Corradi F; Brussino L; Bucca C
Allergy; 2004 Aug; 59(8):827-32. PubMed ID: 15230814
[TBL] [Abstract][Full Text] [Related]
9. Montelukast 10 mg improves nasal function and nasal response to aspirin in ASA-sensitive asthmatics: a controlled study vs placebo.
Micheletto C; Tognella S; Visconti M; Pomari C; Trevisan F; Dal Negro RW
Allergy; 2004 Mar; 59(3):289-94. PubMed ID: 14982510
[TBL] [Abstract][Full Text] [Related]
10. Gene-expression profiles in human nasal polyp tissues and identification of genetic susceptibility in aspirin-intolerant asthma.
Sekigawa T; Tajima A; Hasegawa T; Hasegawa Y; Inoue H; Sano Y; Matsune S; Kurono Y; Inoue I
Clin Exp Allergy; 2009 Jul; 39(7):972-81. PubMed ID: 19489917
[TBL] [Abstract][Full Text] [Related]
11. Study of mediators of anaphylaxis in nasal wash fluids after aspirin and sodium metabisulfite nasal provocation in intolerant rhinitic patients.
Ortolani C; Mirone C; Fontana A; Folco GC; Miadonna A; Montalbetti N; Rinaldi M; Sala A; Tedeschi A; Valente D
Ann Allergy; 1987 Nov; 59(5 Pt 2):106-12. PubMed ID: 3688566
[TBL] [Abstract][Full Text] [Related]
12. Arachidonic acid metabolism in nasal tissue and peripheral blood cells in aspirin intolerant asthmatics.
Schmid M; Göde U; Schäfer D; Wigand ME
Acta Otolaryngol; 1999 Mar; 119(2):277-80. PubMed ID: 10320091
[TBL] [Abstract][Full Text] [Related]
13. [Nasal polyps is not a homogenous pathology].
Arcimowicz M; Balcerzak J; Samoliński BK
Pol Merkur Lekarski; 2005 Sep; 19(111):276-9. PubMed ID: 16358841
[TBL] [Abstract][Full Text] [Related]
14. Increase in urinary leukotriene B4 glucuronide concentration in patients with aspirin-intolerant asthma after intravenous aspirin challenge.
Mita H; Higashi N; Taniguchi M; Higashi A; Akiyama K
Clin Exp Allergy; 2004 Aug; 34(8):1262-9. PubMed ID: 15298568
[TBL] [Abstract][Full Text] [Related]
15. Nasal and bronchial tolerability of Rofecoxib in patients with aspirin induced asthma.
Micheletto C; Tognella S; Guerriero M; Dal Negro R
Eur Ann Allergy Clin Immunol; 2006 Jan; 38(1):10-4. PubMed ID: 16544582
[TBL] [Abstract][Full Text] [Related]
16. Asthma outcomes after endoscopic sinus surgery in aspirin-tolerant versus aspirin-induced asthmatic patients.
Awad OG; Fasano MB; Lee JH; Graham SM
Am J Rhinol; 2008; 22(2):197-203. PubMed ID: 18416980
[TBL] [Abstract][Full Text] [Related]
17. [Melatonin expression in nasal polyps in patients with asthmatic triad].
Evsiukova EV; Okuneva EIu; Zubzhitskaia LB; Kvetnoĭ IM
Arkh Patol; 2008; 70(3):33-5. PubMed ID: 18727430
[TBL] [Abstract][Full Text] [Related]
18. Clinical features of asthmatic patients with increased urinary leukotriene E4 excretion (hyperleukotrienuria): Involvement of chronic hyperplastic rhinosinusitis with nasal polyposis.
Higashi N; Taniguchi M; Mita H; Kawagishi Y; Ishii T; Higashi A; Osame M; Akiyama K
J Allergy Clin Immunol; 2004 Feb; 113(2):277-83. PubMed ID: 14767442
[TBL] [Abstract][Full Text] [Related]
19. Association of three sets of high-affinity IgE receptor (FcepsilonR1) polymorphisms with aspirin-intolerant asthma.
Palikhe NS; Kim SH; Cho BY; Ye YM; Hur GY; Park HS
Respir Med; 2008 Aug; 102(8):1132-9. PubMed ID: 18595682
[TBL] [Abstract][Full Text] [Related]
20. [Asthma with hypersensitivity to aspirin].
Nizankowska-Mogilnicka E
Pol Merkur Lekarski; 2003 Jun; 14(84):561-5. PubMed ID: 14524272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]